Assessment of Antimuscarinics for Treating Overactive Bladder: A Network Meta-Analytic Approach
2011

Adverse Events of Antimuscarinics for Treating Overactive Bladder

Sample size: 26229 publication Evidence: high

Author Information

Author(s): Kessler Thomas M., Bachmann Lucas M., Minder Christoph, Löhrer David, Umbehr Martin, Schünemann Holger J., Kessels Alfons G. H.

Primary Institution: Horten Centre for Patient Oriented Research, University of Zürich, Zürich, Switzerland

Hypothesis

The study aims to compare adverse events of antimuscarinics using a network meta-analytic approach.

Conclusion

Most currently used antimuscarinics seem to be equivalent first choice drugs to start the treatment of OAB except for oral oxybutynin dosages of ≥10 mg/d which may have more unfavorable adverse event profiles.

Supporting Evidence

  • 69 trials enrolling 26,229 patients were included in the analysis.
  • Similar overall adverse event profiles were found for most antimuscarinics except for orally administered oxybutynin.
  • Gastrointestinal side effects were the most frequently reported adverse events.
  • Age, gender, and duration of treatment had no significant influence on adverse events.

Takeaway

This study looked at different medications for overactive bladder and found that most of them are equally good, but one type, oxybutynin, can cause more problems if taken in higher doses.

Methodology

The study included a systematic review and network meta-analysis of randomized controlled trials comparing antimuscarinics for treating OAB.

Potential Biases

There is a potential risk of reporting bias due to variability in adverse event reporting over the years.

Limitations

The study did not account for differences in medication frequency and formulations, and the reporting of adverse events may have been inconsistent across trials.

Participant Demographics

The mean age of participants was 59 years, with 76% being female.

Digital Object Identifier (DOI)

10.1371/journal.pone.0016718

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication